Non-ablative hyperthermic mesenchymal regeneration: a proposed mechanism of action based on the Viveve model

Jeffrey A. Vos; Ryan H. Livengood; Morris Jessop; James E. Coad

doi:10.1117/12.876859

22 February 2011 Non-ablative hyperthermic mesenchymal regeneration: a proposed mechanism of action based on the Vivev model

Jeffrey A. Vos, Ryan H. Livengood, Morris Jessop, James E. Coad

Author Affiliations +

Proceedings Volume 7901, Energy-based Treatment of Tissue and Assessment VI; 790104 (2011) https://doi.org/10.1117/12.876859
Event: SPIE BiOS, 2011, San Francisco, California, United States

Abstract

Novel non-ablative hyperthermic medical devices are currently being developed, in association with cryogen surface cooling, to rejuvenate tissues without collagen scarring. These devices have been designed to remodel skin, manage urinary stress incontinence, and more recently, treat vaginal laxity. In contrast to the thermal injury and reparative healing associated with higher energy ablation systems, these lower energy non-ablative systems are designed to subtly modify the collagen, stimulate the fibroblasts, and maintain a functional tissue architecture that subsequently promotes tissue rejuvenation and restoration. While these devices have primarily relied on clinical outcome questionnaires and satisfaction surveys to establish efficacy, a physiologic explanation for the induced tissue changes and tightening has not been well documented. Recent histology studies, using the Viveve ovine vaginal treatment model, have identified changes that propose both a mechanism of action and a tissue remodeling timeline for such non-ablative hyperthermic devices. The Viveve model results are consistent with subtle connective tissue changes leading to fibroblast stimulation and subsequent collagen replacement and augmentation. Unlike tissue ablation devices that cause thermal necrosis, these non-ablative devices renew the targeted tissue without dense collagenous scarring over a period of 3 or more months. The spectrum of histologic findings, as illustrated in the Viveve ovine vaginal model, further support the previously documented safety and efficacy profiles for low-dose non-ablative hyperthermic devices that rejuvenate and tighten submucosal tissues.

Citation Download Citation

Jeffrey A. Vos, Ryan H. Livengood, Morris Jessop, and James E. Coad "Non-ablative hyperthermic mesenchymal regeneration: a proposed mechanism of action based on the Vivev model", Proc. SPIE 7901, Energy-based Treatment of Tissue and Assessment VI, 790104 (22 February 2011); https://doi.org/10.1117/12.876859

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available